Close Menu

NEW YORK (GenomeWeb) – Circulomics announced today that it has been awarded a $1.5 million Phase II SBIR grant from the National Institutes of Health to develop a single-molecule platform for DNA and RNA sample quality analysis.

According to the company, the platform will be based on its PicoSep instrument, which uses inline isotachophoresis preconcentration and single-molecule free solution hydrodynamic separation to enable DNA and RNA sizing from picoliters of a sample and 20 DNA molecules.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.